<DOC>
	<DOCNO>NCT01840345</DOCNO>
	<brief_summary>This study test whether treatment N-acetyl-L-cysteine ( NAC ) safe decrease pain patient chronic neuropathic pain . The investigator hypothesize NAC useful adjunct opioid treatment chronic neuropathic pain .</brief_summary>
	<brief_title>The Role N-acetyl-l-cysteine ( NAC ) Adjuvant Opioid Treatment Patients With Chronic Neuropathic Pain</brief_title>
	<detailed_description>This open-label study evaluate safety efficacy N-acetyl-L-cysteine patient Chronic neuropathic pain .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1865 year old noncancer neuropathic pain stable dose opioids pain use breakthrough pain med still persistent pain per VAS pregnant nursing serious medical psychiatric illness ( include uncontrolled hypertension ) active stomach ulcer , history seizure asthma breakthrough pain med opioids use illicit drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>uncontrolled</keyword>
	<keyword>neuropathic pain</keyword>
</DOC>